| Survival improvement for patients with metastatic colorectal cancer over twenty years FA Zeineddine, MA Zeineddine, A Yousef, Y Gu, S Chowdhury, A Dasari, ... NPJ Precision Oncology 7 (1), 16, 2023 | 54 | 2023 |
| Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, P Edelkamp, ... NPJ Precision Oncology 8 (1), 27, 2024 | 15 | 2024 |
| Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: a randomized crossover trial JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ... JAMA Network Open 6 (6), e2316161-e2316161, 2023 | 11 | 2023 |
| Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma I Ito, AMG Yousef, S Chowdhury, PN Dickson, ZA Naini, MG White, ... Cancer research 83 (19), 3184-3191, 2023 | 3 | 2023 |
| Serum tumor markers and outcomes in patients with Appendiceal Adenocarcinoma A Yousef, M Yousef, MA Zeineddine, A More, M Fanaeian, S Chowdhury, ... JAMA Network Open 7 (2), e240260-e240260, 2024 | 2 | 2024 |
| Antitumor activity of intraperitoneal (IP) paclitaxel to mucinous appendiceal adenocarcinoma in orthotopic patient-derived xenograft model. I Ito, AMG Yousef, PA Dickson, KF Fournier, NW Fowlkes, JPYC Shen Journal of Clinical Oncology 41 (4_suppl), 151-151, 2023 | 2 | 2023 |
| A prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ... medRxiv, 2022.12. 06.22283164, 2022 | 2 | 2022 |
| 631P Using the unique somatic mutation profile of POLE loss of proof-reading mutation helps in selection of patients who may benefit from immunotherapy G Maddalena, FA Zeineddine, S Chowdhury, M Zeineddine, A Yousef, ... Annals of Oncology 34, S448-S449, 2023 | 1 | 2023 |
| Impact of KRAS Mutations and Co-mutations on Clinical Outcome in Pancreatic Ductal Adenocarcinoma. D Zhao, A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, ... Research Square, rs. 3. rs-3195257, 2023 | 1 | 2023 |
| Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA). MA Zeineddine, FA Zeineddine, AMG Yousef, J Dansby, M White, ... Journal of Clinical Oncology 41 (4_suppl), 226-226, 2023 | 1 | 2023 |
| SO-40 Measurement of circulating tumor DNA (ctDNA) in appendiceal adenocarcinoma (AA): Prevalence, predictors, and correlation with clinical outcome MA Zeineddine, FA Zeineddine, A Yousef, M Overman, M White, A Uppal, ... Annals of Oncology 33, S374, 2022 | 1 | 2022 |
| Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single Institution Case Series AB Pillai, M Yousef, A Yousef, KD Alfaro, BG Smaglo, J Willis, RA Wolff, ... Preprints, 2024 | | 2024 |
| Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma M Yousef, MW Hurd, A Yousef, EB Ludmir, AB Pillai, J Peterson, EJ Koay, ... The Oncologist, oyae182, 2024 | | 2024 |
| 226P Risk of relapse following surgical resection of localized appendiceal adenocarcinoma MM Fanaeian, MMG Yousef, A Yousef, M Taggart, W Foo, K Beaty, ... Annals of Oncology 35, S98, 2024 | | 2024 |
| 227P Clinical outcomes and molecular characterization of appendiceal goblet cell adenocarcinoma in 414 patients A Yousef, MMG Yousef, S Chowdhury, ZA Naini, MM Fanaeian, M Knafl, ... Annals of Oncology 35, S98, 2024 | | 2024 |
| 228P BRAF mutation in appendiceal adenocarcinoma: Key contrasts with colorectal cancer and implications for treatment V Pattalachinti, MMG Yousef, E Haque, A Yousef, S Chowdhury, ... Annals of Oncology 35, S98-S99, 2024 | | 2024 |
| Clinical utility and outcomes associated with mutations detection in liquid biopsy for patients with pancreatic ductal adenocarcinoma: Real-world data evidence from a single … MMG Yousef, MW Hurd, AMG Yousef, A Balachandran Pillai, RA Snyder, ... Journal of Clinical Oncology 42 (16_suppl), 4158-4158, 2024 | | 2024 |
| A phase I/II study of intraperitoneal (IP) paclitaxel (PTX) in patients with metastatic appendiceal adenocarcinoma. JPYC Shen, I Ito, AMG Yousef, M White, KF Fournier, BA Helmink Journal of Clinical Oncology 42 (16_suppl), TPS4215-TPS4215, 2024 | | 2024 |
| Molecular and clinical features of pancreatic acinar cell carcinoma: A single institutional experience. A Balachandran Pillai, MMG Yousef, AMG Yousef, MW Hurd, H Wang, ... Journal of Clinical Oncology 42 (16_suppl), e16335-e16335, 2024 | | 2024 |
| Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma NJ Hornstein, MA Zeineddine, BB Gunes, AJ Pellatt, M Knafl, H Zhu, ... Cancer Research Communications 4 (5), 1363-1368, 2024 | | 2024 |
John Paul ShenAssistant Professor, University of Texas MD Anderson Cancer CenterVerified email at alum.mit.edu
